Dr. David E. Skarda, MD, MBA is a pediatric general surgeon in Salt Lake City, UT specializing in pediatric general surgery, trauma surgery and pediatrics (child & adolescent medicine). He graduated from Albert Einstein College of Medicine of Yeshiva University. Dr. David E. Skarda, MD, MBA is affiliated with Optum, University of Utah Health and OptumCare Utah.
Dr. David E. Skarda, MD, MBA graduated from Albert Einstein College of Medicine of Yeshiva University. He completed residency at University of Minnesota Medical Center, Fairview. He has a state license in Utah.
Medical School: Albert Einstein College of Medicine of Yeshiva University
Residency: University of Minnesota Medical Center, Fairview
Licensed In: Utah
Dr. David E. Skarda, MD, MBA is associated with these hospitals and organizations:
Dr. David E. Skarda, MD, MBA has an exceptional overall rating with an average of 4.84 out of 5 stars based on 14 ratings. We collect ratings and reviews of Dr. David E. Skarda, MD, MBA from all over the web to help you find the right in Salt Lake City, UT.
These charts describe general payments received by Dr. David E. Skarda, MD, MBA. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Boston Scientific Corporation |
$1,734
AXIOS $1,599 |
$135 |
|---|---|---|
| Medical Device Business Services, Inc. |
$61
ENDOPATH ETS Articulating Linear Cutter $61 |
|
| Zimmer Biomet Holdings, Inc. |
$18
MEDLINE $18 |
| Travel and Lodging | $1,480 |
|---|---|
| Food and Beverage | $332 |
Dr. David Skarda is a specialist in trauma surgery and pediatric general surgery. Dr. Skarda has received a 5.0 out of 5 star rating by his patients. After completing medical school at Albert Einstein College of Medicine of Yeshiva University, he performed his residency at the University of Minnesota Medical Center, Fairview. He is conversant in Spanish. His hospital/clinic affiliations include the University of Utah Health and Optum. According to Optum, Dr. Skarda is not acceping new patients at this time.